Mammoth, Agilent Partner on High-Throughput CRISPR-Based Covid-19 Test
Together, the Detectr Boost SARS-CoV-2 Kit and Agilent automated liquid handling system would provide a complete workflow for high-throughput covid-19 testing.
Read MorePosted by Melanie Hamilton-Basich | Feb 1, 2021 | Covid 19 |
Together, the Detectr Boost SARS-CoV-2 Kit and Agilent automated liquid handling system would provide a complete workflow for high-throughput covid-19 testing.
Read MorePosted by Melanie Hamilton-Basich | Jan 15, 2021 | Company News, Covid 19 |
Under the program, Mammoth will leverage its robust DETECTR platform for CRISPR-based diagnostics to detect emerging biological threats.
Read MorePosted by Melanie Hamilton-Basich | Nov 4, 2020 | Covid 19 |
The company has signed agreements with MilliporeSigma to scale manufacturing and with Hamilton Company to market a turnkey solution to help CLIA laboratories rapidly add testing capacity.
Read MorePosted by Melanie Hamilton-Basich | Aug 4, 2020 | Covid 19, Uncategorized |
Mammoth Biosciences’ Detectr test is the first CRISPR-based initiative to be funded by the RADx program.
Read MorePosted by Laurie Bonner | May 28, 2020 | Covid 19, Uncategorized |
The goal is to develop an accurate, easy-to-use, fully disposable, rapid, handheld test that can be used to detect active SARS-CoV-2 infections.
Read More